NDC11 00338040902
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00338-0409-02 | 00338-0409 |
| 00338-0409-2 | 00338-0409 |
| 00338-409-02 | 00338-409 |
| 0338-0409-02 | 0338-0409 |
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 0338-0409 | 0338-0409-02 | D | Discontinued by firm | 2026-08-11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lidocaine Hydrochloride and Dextrose | LIDOCAINE HYDROCHLORIDE | Baxter Healthcare Corporation | f21512ea-c7c3-4766-b976-b2c0b5616bf0 | 2026-02-20 | Warnings, Adverse reactions | 0338-0409-02 0338-0409 00338040902 |